- Home
- CLRB vs DTSS Comparison
CLRB vs DTSS Comparison
Compare CLRB & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- DTSS
- Stock Information
- Founded
- CLRB 2002
- DTSS 2014
- Country
- CLRB United States
- DTSS China
- Employees
- CLRB N/A
- DTSS N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- DTSS Computer Software: Prepackaged Software
- Sector
- CLRB Health Care
- DTSS Technology
- Exchange
- CLRB Nasdaq
- DTSS Nasdaq
- Market Cap
- CLRB 14.2M
- DTSS 16.5M
- IPO Year
- CLRB N/A
- DTSS N/A
- Fundamental
- Price
- CLRB $4.98
- DTSS $2.07
- Analyst Decision
- CLRB Hold
- DTSS
- Analyst Count
- CLRB 2
- DTSS 0
- Target Price
- CLRB N/A
- DTSS N/A
- AVG Volume (30 Days)
- CLRB 154.8K
- DTSS 62.2K
- Earning Date
- CLRB 08-14-2025
- DTSS 09-25-2025
- Dividend Yield
- CLRB N/A
- DTSS N/A
- EPS Growth
- CLRB N/A
- DTSS N/A
- EPS
- CLRB N/A
- DTSS N/A
- Revenue
- CLRB N/A
- DTSS $56,255,129.00
- Revenue This Year
- CLRB N/A
- DTSS N/A
- Revenue Next Year
- CLRB N/A
- DTSS N/A
- P/E Ratio
- CLRB N/A
- DTSS N/A
- Revenue Growth
- CLRB N/A
- DTSS 144.20
- 52 Week Low
- CLRB $4.11
- DTSS $1.63
- 52 Week High
- CLRB $67.50
- DTSS $3.55
- Technical
- Relative Strength Index (RSI)
- CLRB 51.74
- DTSS 54.09
- Support Level
- CLRB $4.43
- DTSS $2.00
- Resistance Level
- CLRB $5.08
- DTSS $2.19
- Average True Range (ATR)
- CLRB 0.40
- DTSS 0.12
- MACD
- CLRB 0.10
- DTSS 0.02
- Stochastic Oscillator
- CLRB 73.11
- DTSS 63.27
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About DTSS Datasea Inc.
Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.